Estimated read time: 2-3 minutes
This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.
[STK]
[IN] HEA MTC
[SU] CXP
TO BUSINESS, AND HEALTH EDITORS:
Sanovas Relocating Its International Operations to World-Class
"BioTech Ready" Facility in San Rafael, Calif., To Accommodate Its
Explosive Growth
SAUSALITO, Calif., April 22, 2014 /PRNewswire/ -- Sanovas Inc.
(www.sanovas.com), a Life Sciences Accelerator developing and
commercializing next-generation micro-invasive diagnostics, devices
and drug delivery technologies, announced today that it is relocating
its business operations next month to a 29,000-sq.-ft. 'BioTech Ready'
facility at 2593 Kerner Blvd., San Rafael, Calif. The relocation is
necessary to accommodate the company's planned expansion.
A previous tenant put $5 million into remodeling and improving the
facility, and spent an additional $5 million on equipment and
technology that will be used immediately by Sanovas. The facility
includes R&D development labs, operating rooms, clean rooms, and ample
office space, as well as a light-industrial warehouse.
"Our relocation to a world-class 29,000-square-foot 'BioTech Ready'
facility will support our aggressive expansion plans," said Larry
Gerrans, Co-Founder, President and CEO. "Our new Headquarters will
enable us to efficiently drive the evolutionary processes of
technology development from concept to commercialization. Sanovas'
portfolio of companies are delivering potentially blockbuster
minimally invasive surgical products that enable surgeons to access,
image, measure, diagnose and treat diseased and obstructed passageways
and anatomies in areas of the human body that have been largely
inaccessible...until now."
"Our city is the home of many great companies, and we are certainly
excited to welcome Sanovas to San Rafael," said Mayor Gary Phillips.
About Sanovas At the heart of the Sanovas companies' scientific
advances is the miniaturization of tools for minimally invasive
surgery, or "M-I-S." Its products extend access beyond current limits,
enabling physicians to diagnose and perform therapeutic interventions
in spaces as small as one millimeter in diameter that have previously
been unreachable. Sanovas expects to commercialize the technology in
coordination with its various partners to address unmet clinical needs
in Oncology, Pulmonology, Cardiology, Neurosurgery, ENT, GI, General
Surgery, Urology and Gynecology.
Read more news from Sanovas.
SOURCE Sanovas
-0- 04/22/2014
/CONTACT: Steve Goldsmith, Sanovas, 415-729-9391 x1023, sgoldsmith@sanovas.com; Ronald Trahan, APR, Ronald Trahan Associates, 508-359-4005 x108, rctrahan@ronaldtrahan.com
/Web Site: http://www.sanovas.com
CO: Sanovas
ST: California
IN: HEA MTC
SU: CXP
PRN
-- PH09270 --
0000 04/22/2014 12:30:00 EDT http://www.prnewswire.com
Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
